The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Biological determinants of endocrine resistance in breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhao, J.-J., Lin, J., Yang, H., Kong, W., He, L., Ma, X., Coppola, D., & Cheng, J. Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806041200 · Cited by 509
RetractedAcharya, C. R., Hsu, D. S., Anders, C. K., Anguiano, A., Salter, K. H., Walters, K. S., Redman, R. C., Tuchman, S. A., Moylan, C. A., Mukherjee, S., et al. (2008) · JAMA · doi:10.1001/jama.299.13.1574 · Cited by 108
RetractedSørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2347 · Cited by 990
Ma, X.-J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.015 · Cited by 954
Wirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2124 · Cited by 891
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
Loi, S., Haibe-Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A., Bergh, J., Foekens, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1522 · Cited by 837
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 817
Outcome signature genes in breast cancer: is there a unique set?
Ein-Dor, L., Kela, I., Getz, G., Givol, D., & Domany, E. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth469 · Cited by 802
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Miller, T. E., Ghoshal, K., Ramaswamy, B., Roy, S., Datta, J., Shapiro, C. L., Jacob, S., & Majumder, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804612200 · Cited by 749
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Dowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A., A'Hern, R., Salter, J., Detre, S., Hills, M., & Walsh, G. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk020 · Cited by 665
Ellis, M. J., Tao, Y., Luo, J., A'Hern, R., Evans, D. B., Bhatnagar, A. S., Chaudri Ross, H. A., von Kameke, A., Miller, W. R., Smith, I., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn309 · Cited by 653
Mechanisms of tamoxifen resistance
Ring, A., & Dowsett, M. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00776 · Cited by 651
Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589
Connections and Regulation of the Human Estrogen Receptor
McDonnell, D. P., & Norris, J. D. (2002) · Science · doi:10.1126/science.1071884 · Cited by 579
Arpino, G., Wiechmann, L., Osborne, C. K., & Schiff, R. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0045 · Cited by 549
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 534
Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521
Controlling nuclear receptors: the circular logic of cofactor cycles
Perissi, V., & Rosenfeld, M. G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1680 · Cited by 510
EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER
Sainsbury, J. R. C., Sherbet, G. V., Farndon, J. R., & Harris, A. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91385-6 · Cited by 492
Gutierrez, M. C., Detre, S., Johnston, S., Mohsin, S. K., Shou, J., Allred, D. C., Schiff, R., Osborne, C. K., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.172 · Cited by 489
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O'Brien, K., Wang, Y., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206937 · Cited by 478
The estrogen receptor: a model for molecular medicine.
Jensen, E. V., & Jordan, V. C. (2003) · PubMed · Cited by 470
Linking cyclins to transcriptional control
Coqueret, O. (2002) · Gene · doi:10.1016/s0378-1119(02)01055-7 · Cited by 431
Estrogen Receptor Mutations in Human Disease
Herynk, M. H., & Fuqua, S. A. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0010 · Cited by 400
Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast Cancer
Colditz, G. A. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.814 · Cited by 399
Zuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y., Liu, X., Chan, M. W. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.034 · Cited by 395
Mechanisms of tamoxifen-induced apoptosis
Mandlekar, S., & Kong, A.-N. T. (2001) · Apoptosis · doi:10.1023/a:1012437607881 · Cited by 394
Loi, S., Haibe-Kains, B., Desmedt, C., Wirapati, P., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Ryder, K., Reid, J. F., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-239 · Cited by 389
deGraffenried, L. A., Friedrichs, W. E., Russell, D. H., Donzis, E. J., Middleton, A. K., Silva, J. M., Roth, R. A., & Hidalgo, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0035 · Cited by 387
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
Oh, D. S., Troester, M. A., Usary, J., Hu, Z., He, X., Fan, C., Wu, J., Carey, L. A., & Perou, C. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2755 · Cited by 356
Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
Jansen, M. P. H. M., Foekens, J. A., van Staveren, I. L., Dirkzwager-Kiel, M. M., Ritstier, K., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Portengen, H., Dorssers, L. C. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.145 · Cited by 340
Boulay, A., Rudloff, J., Ye, J., Zumstein-Mecker, S., O'Reilly, T., Evans, D. B., Chen, S., & Lane, H. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2402 · Cited by 335
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100179 · Cited by 333
Self-citationAromatase inhibitors for breast cancer: lessons from the laboratory
Johnston, S. R. D., & Dowsett, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1211 · Cited by 326
Regulation of Estrogen Rapid Signaling through Arginine Methylation by PRMT1
Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S., & Corbo, L. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.025 · Cited by 324
Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer
Jordan, V. C., & O'Malley, B. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3886 · Cited by 324
CYP2D6 and tamoxifen: DNA matters in breast cancer
Hoskins, J. M., Carey, L. A., & McLeod, H. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2683 · Cited by 322
Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
Hurtado, A., Holmes, K. A., Geistlinger, T. R., Hutcheson, I. R., Nicholson, R. I., Brown, M., Jiang, J., Howat, W. J., Ali, S., & Carroll, J. S. (2008) · Nature · doi:10.1038/nature07483 · Cited by 321
Selective estrogen receptor modulation
Jordan, V. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00059-5 · Cited by 315
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
Deming, S. L., Nass, S. J., Dickson, R. B., & Trock, B. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1522 · Cited by 302
Pathways to tamoxifen resistance
Riggins, R. B., Schrecengost, R. S., Guerrero, M. S., & Bouton, A. H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.016 · Cited by 277
Hankinson, S. E., Colditz, G. A., & Willett, W. C. (2004) · Breast Cancer Research · doi:10.1186/bcr921 · Cited by 270
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
Kirkegaard, T., Witton, C. J., McGlynn, L. M., Tovey, S. M., Dunne, B., Lyon, A., & Bartlett, J. M. (2005) · The Journal of Pathology · doi:10.1002/path.1829 · Cited by 268
c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry
Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., & Sutherland, R. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4499 · Cited by 267
Self-citationCreighton, C. J., Casa, A., Lazard, Z., Huang, S., Tsimelzon, A., Hilsenbeck, S. G., Osborne, C. K., & Lee, A. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4429 · Cited by 260
McClelland, R. A., Barrow, D., Madden, T., Dutkowski, C. M., Pamment, J., Knowlden, J. M., Gee, J. M. W., & Nicholson, R. I. (2001) · Endocrinology · doi:10.1210/en.142.7.2776 · Cited by 258
Arpino, G., Green, S. J., Allred, D. C., Lew, D., Martino, S., Osborne, C. K., & Elledge, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0110 · Cited by 255
Butt, A. J., McNeil, C. M., Musgrove, E. A., & Sutherland, R. L. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00993 · Cited by 244
Self-citationCell cycle control in breast cancer cells
Caldon, C. E., Daly, R. J., Sutherland, R. L., & Musgrove, E. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20690 · Cited by 238
Self-citationBcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
Callagy, G. M., Pharoah, P. D., Pinder, S. E., Hsu, F. D., Nielsen, T. O., Ragaz, J., Ellis, I. O., Huntsman, D., & Caldas, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2719 · Cited by 237
Iorns, E., Turner, N. C., Elliott, R., Syed, N., Garrone, O., Gasco, M., Tutt, A. N. J., Crook, T., Lord, C. J., & Ashworth, A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.001 · Cited by 230
Shi, L., Dong, B., Li, Z., Lu, Y., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2254 · Cited by 226
Cariou, S., Donovan, J. C. H., Flanagan, W. M., Milic, A., Bhattacharya, N., & Slingerland, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160016897 · Cited by 224
Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo
Schiff, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1926 · Cited by 211
Chemoprevention of breast cancer with selective oestrogen-receptor modulators
Jordan, V. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2048 · Cited by 206
Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
Zhou, Y., Yau, C., Gray, J. W., Chew, K., Dairkee, S. H., Moore, D. H., Eppenberger, U., Eppenberger-Castori, S., & Benz, C. C. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-59 · Cited by 203
Chanrion, M., Negre, V., Fontaine, H., Salvetat, N., Bibeau, F., Grogan, G. M., Mauriac, L., Katsaros, D., Molina, F., Theillet, C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1833 · Cited by 203
Activation of PI3K/Akt signaling and hormone resistance in breast cancer
Tokunaga, E., Kimura, Y., Mashino, K., Oki, E., Kataoka, A., Ohno, S., Morita, M., Kakeji, Y., Baba, H., & Maehara, Y. (2006) · Breast Cancer · doi:10.2325/jbcs.13.137 · Cited by 199
Gasparini, G., Barbareschi, M., Doglioni, C., Palma, P., Mauri, F. A., Boracchi, P., Bevilacqua, P., Caffo, O., Morelli, L., & Verderio, P. (1995) · PubMed · Cited by 193
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192
Gomez, B. P., Riggins, R. B., Shajahan, A. N., Klimach, U., Wang, A., Crawford, A. C., Zhu, Y., Zwart, A., Wang, M., & Clarke, R. (2007) · The FASEB Journal · doi:10.1096/fj.06-7990com · Cited by 188
Davies, M. P. A., Barraclough, D. L., Stewart, C., Joyce, K. A., Eccles, R. M., Barraclough, R., Rudland, P. S., & Sibson, D. R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23479 · Cited by 177
Helleman, J., Jansen, M. P. H. M., Ruigrok-Ritstier, K., van Staveren, I. L., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Klijn, J. G. M., Sleijfer, S., Foekens, J. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0555 · Cited by 174
Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells
Hutcheson, I. R., Knowlden, J. M., Madden, T.-A., Barrow, D., Gee, J. M. W., Wakeling, A. E., & Nicholson, R. I. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025484908380 · Cited by 169
Miller, T. W., Pérez-Torres, M., Narasanna, A., Guix, M., Stål, O., Pérez-Tenorio, G., Gonzalez-Angulo, A. M., Hennessy, B. T., Mills, G. B., Kennedy, J. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0042 · Cited by 168
The NFκB pathway and endocrine-resistant breast cancer
Zhou, Y., Eppenberger-Castori, S., Eppenberger, U., & Benz, C. C. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00977 · Cited by 166
Linking oncogenic pathways with therapeutic opportunities
Bild, A. H., Potti, A., & Nevins, J. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1976 · Cited by 163
Aromatase Inhibitors for Breast Cancer Prevention
Cuzick, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.027 · Cited by 161
Carroll, J. S., Prall, O. W. J., Musgrove, E. A., & Sutherland, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004424200 · Cited by 158
Self-citationJohnston, S. R. D., Lü, B., Scott, G. K., Kushner, P. J., Smith, I. E., Dowsett, M., & Benz, C. C. (1999) · PubMed · Cited by 153
Brinkman, A., van der Flier, S., Kok, E. M., & Dorssers, L. C. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.112 · Cited by 146
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
Shoman, N. M., Klassen, S., McFadden, A., Bickis, M., Torlakovic, E., & Chibbar, R. (2004) · Modern Pathology · doi:10.1038/modpathol.3800296 · Cited by 142
Molecular Concepts Analysis Links Tumors, Pathways, Mechanisms, and Drugs
Rhodes, D. R., Sundaram, S. K., Tomlins, S. A., Mahavisno, V., Kasper, N. M., Varambally, R., Barrette, T. R., Ghosh, D., Varambally, S., & Chinnaiyan, A. M. (2007) · Neoplasia · doi:10.1593/neo.07292 · Cited by 139
Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance
Schoenlein, P., Periyasamy‐Thandavan, S., Samaddar, J. S., Jackson, W., & Barrett, J. (2009) · Autophagy · doi:10.4161/auto.5.3.7784 · Cited by 138
NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen
deGraffenried, L. A., Chandrasekar, B., Friedrichs, W. E., Donzis, E. J., Silva-Fisher, J., Hidalgo, M. M., Freeman, J. W., & Weiss, G. R. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh232 · Cited by 136
Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer
Dowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A. I., Griffith, C. D. M., Boeddinghaus, I., Salter, J., DETRE, S. I., Hills, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2127 · Cited by 131
Kalish, L. H., Kwong, R. A., Cole, I. E., Gallagher, R. M., Sutherland, R. L., & Musgrove, E. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0012 · Cited by 127
Self-citationvan Agthoven, T., van Agthoven, T. L. A., Dekker, A., van der Spek, P. J., Vreede, L., & Dorssers, L. C. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2799 · Cited by 122
Liu, R., Wang, L., Chen, G., Katoh, H., Chen, C., Liu, Y., & Zheng, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3717 · Cited by 121
Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
Yu, J. X., Sieuwerts, A. M., Zhang, Y., Martens, J. W. M., Smid, M., Klijn, J. G. M., Wang, Y., & Foekens, J. A. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-182 · Cited by 121
Mukherjee, S., & Conrad, S. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502278200 · Cited by 120
Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment
van der Flier, S., Brinkman, A., Look, M. P., Kok, E. M., Gelder, M. E. M., Klijn, J. G. M., Dorssers, L. C. J., & Foekens, J. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.120 · Cited by 119
Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer Cells
Meijer, D., van Agthoven, T., Bosma, P. T., Nooter, K., & Dorssers, L. C. J. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0156 · Cited by 117
van Agthoven, T., Sieuwerts, A. M., Gelder, M. E. M., Look, M. P., Smid, M., Veldscholte, J., Sleijfer, S., Foekens, J. A., & Dorssers, L. C. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1462 · Cited by 110
Hui, R., Finney, G. L., Carroll, J. S., Lee, C. S. L., Musgrove, E. A., & Sutherland, R. L. (2002) · PubMed · Cited by 109
Self-citationNovel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations
Gururaj, A. E., Rayala, S. K., Vadlamudi, R. K., & Kumar, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2110 · Cited by 109
Musgrove, E. A., Sergio, C. M., Loi, S., Inman, C. K., Anderson, L. R., Alles, M. C., Pinese, M., Caldon, C. E., Schütte, J., Gardiner‐Garden, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002987 · Cited by 101
Self-citationAntiestrogens, Aromatase Inhibitors, and Apoptosis in Breast Cancer
Riggins, R. B., Bouton, A. H., Liu, M., & Clarke, R. C. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71007-4 · Cited by 97
Gu, Z., Lee, R. Y., Skaar, T. C., Bouker, K. B., Welch, J. N., Lu, J., Liu, A., Zhu, Y. J., Davis, N., Leonessa, F., et al. (2002) · PubMed · Cited by 97
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Span, P. N., Tjan‐Heijnen, V. C. G., Manders, P., Beex, L. V. A. M., & Sweep, F. C. G. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206818 · Cited by 93
Millar, E. K. A., Dean, J. L., McNeil, C. M., O’Toole, S. A., Henshall, S. M., Tran, T. H., Lin, J., Quong, A. A., Comstock, C. E. S., Witkiewicz, A. K., et al. (2009) · Oncogene · doi:10.1038/onc.2009.13 · Cited by 88
Self-citationSynergistic Promotion of c-Src Activation and Cell Migration by Cas and AND-34/BCAR3
Riggins, R. B., Quilliam, L. A., & Bouton, A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303535200 · Cited by 85
Cai, D. D., Iyer, A., Felekkis, K. N., Near, R. I., Luo, Z., Chernoff, J., Albanese, C., Pestell, R. G., & Lerner, A. (2003) · PubMed · Cited by 85
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity
deGraffenried, L. A., Friedrichs, W. E., Fulcher, L. C., Fernandes, G., Silva-Fisher, J., Peralba, J.-M., & Hidalgo, M. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg291 · Cited by 81
Murphy, L. C., Niu, Y., Snell, L., & Watson, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0191 · Cited by 78
Meijer, D., Sieuwerts, A. M., Look, M. P., van Agthoven, T., Foekens, J. A., & Dorssers, L. C. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0080 · Cited by 77
Wang, Y., Dean, J. L., Millar, E. K. A., Tran, T. H., McNeil, C. M., Burd, C. J., Henshall, S. M., Utama, F. E., Witkiewicz, A. K., Rui, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3170 · Cited by 76
Self-citationIs oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?
Murphy, L. C., & Watson, P. H. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01141 · Cited by 74
Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc
Caldon, C. E., Sergio, C. M., Schütte, J., Boersma, M. N., Sutherland, R. L., Carroll, J. S., & Musgrove, E. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00269-09 · Cited by 71
Self-citationDorssers, L. C. J., van Agthoven, T., Dekker, A., van Agthoven, T. L., & Kok, E. M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.7.8413311 · Cited by 71
Venditti, M., Iwasiow, B. M., Orr, F. W., & Shiu, R. P. C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10269 · Cited by 69
Kok, M., Linn, S. C., van Laar, R. K., Jansen, M. P. H. M., van den Berg, T. M., Delahaye, L. J. M. J., Glas, A. M., Peterse, J. L., Hauptmann, M., Foekens, J. A., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9939-y · Cited by 66
Pérez‐Tenorio, G., Berglund, F., Merca, A. E., Nordenskjöld, B. A., Rutqvist, L. E., Skoog, L. K., & Stål, O. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1031 · Cited by 65
Growth factor signalling in endocrine and anti-growth factor resistant breast cancer
Nicholson, R. I., Hutcheson, I. R., Jones, H. E., Hiscox, S., Giles, M. G., Taylor, K. M., & Gee, J. M. W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9033-5 · Cited by 62
Harvell, D. M. E., Spoelstra, N. S., Singh, M., McManaman, J. L., Finlayson, C. A., Phang, T. L., Trapp, S., Hunter, L., Dye, W. W., Borges, V. F., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9897-4 · Cited by 59
Ishii, Y., Waxman, S., & Germain, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2879 · Cited by 56
The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer
Dorssers, L. C. J., Grebenchtchikov, N. I., Brinkman, A., Look, M. P., van Broekhoven, S. P. J., de Jong, D., Peters, H. A., Portengen, H., Gelder, M. E. M., Klijn, J. G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0444 · Cited by 54
Functional identification of genes causing estrogen independence of human breast cancer cells
van Agthoven, T., Veldscholte, J., Smid, M., AGTHOVEN, T. L. A. V., Vreede, L., Broertjes, M., de Vries, I., de Jong, D., Sarwari, R., & Dorssers, L. C. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9969-5 · Cited by 53
Pohl, G., Rudas, M., Dietze, O., Lax, S., Markis, E., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., Samonigg, H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.021 · Cited by 53
Ta, H. Q., Thomas, K. S., Schrecengost, R. S., & Bouton, A. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2426 · Cited by 52
Dhillon, N. K., & Mudryj, M. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205576 · Cited by 50
Bad expression predicts outcome in patients treated with tamoxifen
Cannings, E., Kirkegaard, T., Tovey, S., Dunne, B., Cooke, T. G., & Bartlett, J. M. S. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9323-8 · Cited by 49
Yu, K., Ganesan, K., Miller, L. D., & Tan, P. B. O. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1530 · Cited by 45
Carroll, J. S., Lynch, D. K., Swarbrick, A., Renoir, J., Šarčević, B., Daly, R. J., Musgrove, E. A., & Sutherland, R. L. (2003) · PubMed · Cited by 44
Self-citationThe endocrine prevention of breast cancer
Howell, A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.002 · Cited by 43
Hua, G., Zhu, B., Rosa, F., Deblon, N., Adélaïde, J., Kahn‐Perlès, B., Birnbaum, D., & Imbert, J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0175 · Cited by 42
A Transcriptional Fingerprint of Estrogen in Human Breast Cancer Predicts Patient Survival
Yu, J., Yu, J., Cordero, K. E., Johnson, M. D., Ghosh, D., Rae, J. M., Chinnaiyan, A. M., & Lippman, M. E. (2008) · Neoplasia · doi:10.1593/neo.07859 · Cited by 33
Harvell, D. M. E., Richer, J. K., Singh, M., Spoelstra, N. S., Finlayson, C. A., Borges, V. F., ELIAS, A. D., & Horwitz, K. B. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9923-6 · Cited by 33
Varma, H., Skildum, A. J., & Conrad, S. E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001256 · Cited by 30
Meijer, D., Jansen, M. P. H. M., Look, M. P., Ruigrok-Ritstier, K., van Staveren, I. L., Sieuwerts, A. M., van Agthoven, T., Foekens, J. A., Dorssers, L. C. J., & Berns, E. M. J. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9934-3 · Cited by 29
Planas-Silva, M. D., & Hamilton, K. N. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0398-z · Cited by 26
Leary, A. F., Sirohi, B., & Johnston, S. R. D. (2007) · Breast Cancer Research · doi:10.1186/bcr1763 · Cited by 24
Soni, S., Lin, B., August, A., Nicholson, R. I., & Kirsch, K. H. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22136 · Cited by 20
Brinkman, A., de Jong, D., Tuinman, S., Azaouagh, N., van Agthoven, T., & Dorssers, L. C. J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0403-4 · Cited by 19
Live or let die: oestrogen regulation of survival signalling in endocrine response
Butt, A. J., Sutherland, R. L., & Musgrove, E. A. (2007) · Breast Cancer Research · doi:10.1186/bcr1779 · Cited by 16
Self-citation
Cited by
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Self-citationMechanisms of Endocrine Resistance in Breast Cancer
Osborne, C. K., & Schiff, R. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-070909-182917 · Cited by 1,166
Gene expression profiling in breast cancer: classification, prognostication, and prediction
Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 729
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Jeselsohn, R., Buchwalter, G., De Angelis, C., Brown, M., & Schiff, R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.117 · Cited by 704
Metadata
- Authors
- Musgrove, E. A., & Sutherland, R. L.
- Venue
- Nature Reviews Cancer
- Published
- 2009-09
- Volume
- 9
- Issue
- 9
- Pages
- 631-643
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2013956549
- Cited by
- 1,252
- References
- 143
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.